🇦🇹 Austria Country × Condition
acute lymphoblastic leukemia Clinical Trials in Austria
Active clinical trials for acute lymphoblastic leukemia with research sites in Austria. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 2, Phase 3 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇦🇹 Austria
Active Trials in Austria (3)
NCT02872987
Recruiting
GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
Enrollment
10,000 pts
Country
🇦🇹 Austria
Goethe University
View Trial → NCT05748171 Phase 2
Recruiting
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Enrollment
100 pts
Country
🇦🇹 Austria
Pfizer
View Trial → NCT05327894 Phase 3
Recruiting
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Enrollment
160 pts
Country
🇦🇹 Austria
Princess Maxima Center for Pediatri...
View Trial → Frequently Asked Questions
How many acute lymphoblastic leukemia clinical trials are active in Austria?
There are currently 3 active clinical trials for acute lymphoblastic leukemia with sites in Austria, of which 3 are actively recruiting patients.
How can I join a acute lymphoblastic leukemia clinical trial in Austria?
To join a acute lymphoblastic leukemia clinical trial in Austria, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Austria directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are acute lymphoblastic leukemia trials in Austria?
Active acute lymphoblastic leukemia trials in Austria span Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology